id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
HHS-OPHS-2015-0002-0001,HHS,HHS-OPHS-2015-0002,"Draft Guidance for Industry, Clinical Investigators, and Institutional Review Boards—Use of an Electronic Informed Consent in Clinical Investigations - Questions and Answers; Availability",Notice,,2015-03-09T04:00:00Z,2015,3,2015-03-09T04:00:00Z,2015-05-08T03:59:59Z,2015-05-18T13:24:58Z,2015-05301,0,0,0900006481a3403f
HHS-OPHS-2015-0002-0002,HHS,HHS-OPHS-2015-0002,FDA Draft Guidance on Use of Electronic Informed Consent in Clinical Investigations,Supporting & Related Material,,2015-03-09T04:00:00Z,2015,3,,,2015-03-09T15:12:21Z,,0,0,0900006481a34040